This topic contains a solution. Click here to go to the answer

Author Question: In a clinical trial, each participant will receive a placebo, a low dosage of a drug, or a high ... (Read 93 times)

Jipu 123

  • Hero Member
  • *****
  • Posts: 569
In a clinical trial, each participant will receive a placebo, a low dosage of a drug, or a high dosage of the drug. The participants consist of 90 men and 90 women. The 90 men are randomly divided into three groups of 30 men each.
 
  Each group of men is randomly assigned to a different treatment (placebo, low dose, or high dose). Likewise, the 90 women are randomly divided into three groups of 30 women each. Each group of women is randomly assigned to a different treatment (placebo, low dose, or high dose). Is this a completely randomized design or a randomized block design? Explain your answer.

Question 2

x = 21, n = 30
 
  A) Not appropriate B) Appropriate



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bitingbit

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

This is a randomized block design. Explanations will vary.

Answer to Question 2

B




Jipu 123

  • Member
  • Posts: 569
Reply 2 on: Jul 25, 2018
Gracias!


bimper21

  • Member
  • Posts: 309
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library